Research
Education
Solutions
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
School of Biomedical Sciences & Curtin Health Innovation Research Institute
Caryn L. Elsegood has not added Biography.
If you are Caryn L. Elsegood and would like to personalize this page please email our Author Liaison for assistance.
An investigation by electron microscopy of chylomicron remnant uptake by human monocyte-derived macrophages.
Atherosclerosis Oct, 2006 | Pubmed ID: 16310792
M-CSF induces the stable interaction of cFms with alphaVbeta3 integrin in osteoclasts.
The international journal of biochemistry & cell biology , 2006 | Pubmed ID: 16600665
Glycolytic control of adjuvant-induced macrophage survival: role of PI3K, MEK1/2, and Bcl-2.
Journal of leukocyte biology Jun, 2009 | Pubmed ID: 19270084
Phosphatidylinostitol-3 kinase and phospholipase C enhance CSF-1-dependent macrophage survival by controlling glucose uptake.
Cellular signalling Sep, 2009 | Pubmed ID: 19376223
Hypoxia prolongs monocyte/macrophage survival and enhanced glycolysis is associated with their maturation under aerobic conditions.
Journal of immunology (Baltimore, Md. : 1950) Jun, 2009 | Pubmed ID: 19494322
Glucose metabolism is required for oxidized LDL-induced macrophage survival: role of PI3K and Bcl-2 family proteins.
Arteriosclerosis, thrombosis, and vascular biology Sep, 2009 | Pubmed ID: 19667115
Invading macrophages play a major role in the liver progenitor cell response to chronic liver injury.
Journal of hepatology Sep, 2010 | Pubmed ID: 20561705
Kupffer cell-monocyte communication is essential for initiating murine liver progenitor cell-mediated liver regeneration.
Hepatology (Baltimore, Md.) Oct, 2015 | Pubmed ID: 26173184
Divergent Inflammatory, Fibrogenic, and Liver Progenitor Cell Dynamics in Two Common Mouse Models of Chronic Liver Injury.
The American journal of pathology Jul, 2016 | Pubmed ID: 27181403
Identification of a thalidomide derivative that selectively targets tumorigenic liver progenitor cells and comparing its effects with lenalidomide and sorafenib.
European journal of medicinal chemistry Sep, 2016 | Pubmed ID: 27208658
Curtin University
Jully Gogoi-Tiwari1,
Julia Köhn-Gaone1,
Corey Giles2,
Dirk Schmidt-Arras3,
Francis D. Gratte1,4,
Caryn L. Elsegood1,
Geoffrey W. McCaughan5,6,7,
Grant A. Ramm8,9,
John K. Olynyk10,11,
Janina E.E. Tirnitz-Parker1,12
1School of Biomedical Sciences & Curtin Health Innovation Research Institute, Curtin University,
2School of Public Health & Curtin Health Innovation Research Institute, Curtin University,
3Institute of Biochemistry, Christian-Albrechts-University,
4School of Veterinary and Life Sciences, Murdoch University,
5Centenary Institute of Cancer Medicine and Cell Biology, The University of Sydney,
6, Royal Prince Alfred Hospital,
7, A.W. Morrow Gastroenterology and Liver Centre,
8, QIMR Berghofer Medical Research Institute,
9Faculty of Medicine and Biomedical Sciences, The University of Queensland,
10, Fiona Stanley and Fremantle Hospitals,
11School of Medical and Health Sciences, Edith Cowan University,
12School of Medicine and Pharmacology, University of Western Australia
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved